BACE1, a Major Determinant of Selective Vulnerability of the Brain to Amyloid-β Amyloidogenesis, is Essential for Cognitive, Emotional, and Synaptic Functions
Open Access
- 14 December 2005
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 25 (50), 11693-11709
- https://doi.org/10.1523/jneurosci.2766-05.2005
Abstract
A transmembrane aspartyl protease termed β-site APP cleavage enzyme 1 (BACE1) that cleaves the amyloid-β precursor protein (APP), which is abundant in neurons, is required for the generation of amyloid-β (Aβ) peptides implicated in the pathogenesis of Alzheimer's disease (AD). We now demonstrate that BACE1, enriched in neurons of the CNS, is a major determinant that predisposes the brain to Aβ amyloidogenesis. The physiologically high levels of BACE1 activity coupled with low levels of BACE2 and α-secretase anti-amyloidogenic activities in neurons is a major contributor to the accumulation of Aβ in the CNS, whereas other organs are spared. Significantly, deletion ofBACE1inAPPswe;PS1ΔE9mice prevents both Aβ deposition and age-associated cognitive abnormalities that occur in this model of Aβ amyloidosis. Moreover, Aβ deposits are sensitive toBACE1dosage and can be efficiently cleared from the CNS whenBACE1is silenced. However,BACE1null mice manifest alterations in hippocampal synaptic plasticity as well as in performance on tests of cognition and emotion. Importantly, memory deficits but not emotional alterations inBACE1–/–mice are prevented by coexpressingAPPswe;PS1ΔE9transgenes, indicating that other potential substrates of BACE1 may affect neural circuits related to emotion. Our results establish BACE1 and APP processing pathways as critical for cognitive, emotional, and synaptic functions, and future studies should be alert to potential mechanism-based side effects that may occur with BACE1 inhibitors designed to ameliorate Aβ amyloidosis in AD.This publication has 97 references indexed in Scilit:
- Age and time-of-day effects on learning and memory in a non-matching-to-sample testNeurobiology of Aging, 2004
- Cleavage of Amyloid-β Precursor Protein and Amyloid-β Precursor-like Protein by BACE 1Online Journal of Public Health Informatics, 2004
- Isoform‐specific knockout of FE65 leads to impaired learning and memoryJournal of Neuroscience Research, 2003
- Mild cognitive impairment clinical trialsNature Reviews Drug Discovery, 2003
- Killing the messenger: short RNAs that silence gene expressionNature Reviews Molecular Cell Biology, 2003
- The Transcriptional Activity of the APP Intracellular Domain−Fe65 Complex Is Inhibited by Activation of the NF-κB PathwayBiochemistry, 2003
- NOTCH ANDPRESENILIN: Regulated Intramembrane Proteolysis Links Development and DegenerationAnnual Review of Neuroscience, 2003
- Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease modelAnnals of Neurology, 2000
- Facilitation of currents through rat Ca2+‐permeable AMPA receptor channels by activity‐dependent relief from polyamine blockJournal Of Physiology-London, 1998
- β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activityCell, 1995